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Abstract: The aim of this study were to assess the presence of HPV esophageal infection 
among Iranian Turkrnen who live in an area located in the cancer belt in Asia. The 
specimens derived from 120 patients previously diagnosed for Squamous Cell Carcinoma 
(SCC) non-cancerous tissue derived from esophagus. All specimens were examined for the 
presence of HPV DNA. PCR was utilized to amplify a 150 bp segment of HPV Ll gene 
using the consensus primers. The amplified region was subsequently sequenced to identify 
the HPV genotypes. The HPV DNA was detected in 49.4% ofpatients with SCC, and 58% 
of non-cancerous tissue of esophagus. The positive samples included HPV-16 ( 46.6%), 
HPV-6 (24.6%), HPV-66 (8.2%), HPV-52 ( 4.1 %), HPV-18 (2.7%); 14% of cases were 
positive for more than one type of HPV. The results confirm the presence of HPV in both 
esophageal cancerous and non-cancerous tissues.These results imply two different 
interpretations: 1) Due to non-significant difference between the rate of HPV positive in 
cancerous and non-cancerous tissues, HPV has no important role in esophageal cancers, 
which is less probable. 2). Because of a highly incidence of esophageal cancer in 
Turkmen-Sahra region, the HPV is a possible etiologic agent in esophageal carcinogenesis, 
most probably acting synergistically with physical, chemical, and/or nutritional factors that 
have previously been folllld to be related to this malignancy in Turkrnen-Sahra. 
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Introduction 
Esophageal carcinoma has a striking geographical distribution. The incidence is remarkably 
high in certain region of Iran, in China and South Africa. The highest incidence of this highly 
malignant tumor is encolllltered in the northeast of Iran, particularly in the Turkrnen Sahra 
(Kem! et al., 1980; Oneill et al., 1980; Kmet and Mahboubi, 1972). 
The causative factor of this disease remains to be established (Kemt et al., 1980; Oneill et al., 
1980; Kmet; Mahboubi, 1972; Munoz et al., 1982; Muhboubi et al., 1973). Cigarette smoking and 
excess alcohol intake may be risk factors in some areas (e.g. Western colUltries and South Africa), 
especially when the two factors are combined. Nevertheless, these factors do not appear to be a 
problem in Iran (Editorial, 1978; IARC, 1977; Crespi, 1979). Previous studies in Iran show, specific 
nutritional deficiencies such as vitamin A, B, C and certain minerals, as well as nitrosamines formed 
in moldy food stuffs my be important (Horrnozidari et al., 1975; Cook-Mozaffari et al., 1979; 
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Ghadirian, 1987). Furthermore, opium tar has been blamed as possible risk factor (Kernt et al., 1980; 
IARC, 1977). It is more likely that these factors may render the esophageal mucus membrane, more 
susceptible to injury by carcinogens including rnycotox:ins, nitrosyl compound, and possibly viruses. 
HPV plays an important role in the development of squamous cell carcinomas in various body 
sites, including the anogenital (Hausen and Villiers, 1994), upper respiratory and digestive tracts 
(Chen et al., 1994; Chang et al., 1990; Chang et al., 1993; Kulski et al., 1986; Loke et al., 1990; 
Benzrnouzig et al., 1992; Toh, 1992; Togawa et al., 1994). Eighty-five types of HPV have been 
described in full and 120 types have been partially characterized (Hausen, 1999). HPV types 6, 11, 
16, 18 and 31 represent the most common types found in the epithelium of squamous cell hyperplasia, 
dysplasia, and carcinomas (Chang et al., 1990). Based on their association with neoplasm's in the 
anogeital tract, HPV types can be categorized as high-risk types (HPV-16, 18 and 31) and low risk 
types (HPV-6, 11). 
Members of the high-risk group promote carcinogensis and their DNA usually integrates in to the 
host genome, whereas the low risk HPV types which are primarily found in benign tumors and their 
DNA remain extra chromosomal (Toh et al., 1992). HPV-6, 11, 16, 18, and 31 have been described in 
association with esophageal squamous cell lesions (Maniatis et al., 1989). However, the incidence of 
HPV positively varies significantly depending and the geographic location of the patient. Studies that 
suggest a role for the HPV play in the genesis of esophageal carcinoma almost invariably involve a 
population, which is at a high risk for development of esophageal carcinoma (Chen et al., 1994; 
Chang et al., 1993). Our aim was to determine the incidence of various HPV types in the specimen 
obtained from esophagus (cancerous and non-cancerous tissues) based on the DNA sequence ofLl 
gene, which is the most widely gene used in PCR assay and can be detected a segment of the gene 
encoding the L 1 major capsid protein, that is common to all HPV types. 
Materials and Methods 
A total of 116-esophageal samples, 74 men and 42 women, aged between 42 to 85 years were 
removed by biopsy from patient in Turkmen Sabra and were studied in the Institute of Public Health 
and Research at the Tehran University of Medical Sciences. All specimens received were fixed in 10% 
buffered formalin, processed routinely, and embedded in paraffin. For each case, all available 
hematoxylin and eosin stained sections were reviewed. Eightyfive samples were diagnosed cancerous 
(squamous cell carcinoma), and thirty-one non-cancerous tissues (esophagitis, and moco-epithelial cell) 
of esophagus. 
Sample preparation 
Genomic DNA was extracted by the standard proteinase K/phenol method (Saiki et al., 1985). 
After ethanol precipitation, the DNA was resuspended in TE buffer (10 mM Tris-HCL lmM 
EDTA) and quantified by measuring absorbance at 260 nm. DNA concentration of more 
than 10 ng µL - 1 were judged as suitable for further studies. DNA samples were then checked by 
agarose gel electrophoresis to verify that degradation had not occurred during the extraction. Samples 
containing 100 ng of purified DNA were used for PCR amplification according to the following 
procedure (Saiki et al., 1988). 
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Polymerase Chain Reaction (PCR) 
A slight modification of the PCR method described by Saiki et al. (1988) was used. PCR was 
performed in a total volume of 50 µL containing 100 ng DNA of extracted from paraffin-embedded 
tissue, 50 mM KCL, 10 mM Tris-HCL pH 8.3, 200 µM of each dNTP, MgCl, at between 2 and 
4 rnM, 1 U Taq polymerase and 50 prnol each primer. The primers used in this study were 
GP5+/GP6+ pairs with the following sequences (de Roda Husman et al. (1995) modified in German 
Cancer Research Center): 
GP5+5'TTGGATCCTTTGTT AACTGTGGTAGATACTAC 
GP6+5'TTGGATCCGAAAAATAAACTGTAAATCATATTC 
The mixture was denatured at 94°C for 5 min, followed by 40 cycles of amplification using a 
PCR processor Bio-Med (Perkin Elmer Cetus USA). Each cycle consisted of 94°C for 1.5 min 40°C 
for 2 min and 72°C for 1.5 min. The final elongation step was prolonged for 4 min to ensure complete 
extension of the amplified product. Samples processing prior to and after the amplification reactions 
were performed in strictly separated rooms to avoid contamination by PCR products. Samples 
containing distilled water were used as negative controls. Ten microliter of each the PCR mixture was 
finally analyzed by 1.5% agarose gel electrophoresis (Saiki et al., 1995). 
Sequence analysis ofPCR products 
PCR amplified products (124 bp) were purified with commercial PCR product purification Kit 
(Baeringer Mannheim Germany). Approximately, 25 ng of the purified amplified DNA product was 
subjected to nucleotide sequence analysis with 20 pmoles ofM13 forward (-20) and reverse primers 
with the following sequences. Ml3 forward (-20) priming sit S'GTAAAACGACGGCCAG, Ml3 
reveres priming sit 5' CAGGAAACAGCTATGAC. The sequencing was performed using 
commercial sequencing Kit (Perkin Elmer USA). Subsequently, X-ray film autoradiography was 
then performed to reveal the nucleotide of different HPV DNA. 
Results and Discussion 
DNA of 85 patients with squamous cell carcinoma and 31 non-cancerous of esophagus was 
amplifiable in every sample as determined by amplification of p-globin gene. Forty-two samples 
of squamous cell carcinoma and eighteen ofnon-cancerous tissue were PCR positive using primers of 
the HPV Ll gene. The sex distribution of the patient with esophageal cancer HPV was positive 52.8% 
male and 43.7% female, in non-cancerous 66.6 and 33.3%, respectively (Table 1). 
Tablel: Frequency ofHPV types in esophageal squamous cell carcinoma and non-cancerous tissue of esophagus 
Squamous cell carcinoma Non-cancerous tissue of esophagus 
HPVtypes Frequency % Frequency % 
HPV-6 6 14.3 8 44.4 
HPV-16 23 54.7 7 38.8 
HPV-18 2 4.8 
HPV-66 3 7.1 5.5 
HPV-52 2 4.8 2 11.1 
HPV-6, 18 4 9.2 
HPV-16, 18 2 4.8 
Total 42 100 18 100 
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Esophageal carcinoma has a distinct geographic distribution with a high prevalence in certain 
regions of Iran, china, Africa and France (Toh et al., 1992). This variation of the diseases stern in part 
from environmental factors such as the mineral content of the soil, dietary practices, occupational 
factors, and personal habits (\Vhelan et al., 1990). Viral infections may also play a role in the genesis 
of esophageal carcinoma in some population (Chang et al., 1992). In 1982, Syrjanen published his 
observation on the present ofhistologic changes consistent with those on condylorna in esophageal 
squamous cell cancer (Chang et al., 1990). This observation showed etiological role of HPV infection 
in the development of esophageal carcinoma. An association between HPV and esophageal carcinoma 
has been previously reported in China (Chen 1994; Chang et al., 1990, 1993), France (Benarnouzig 
et al., 1992), Italy (Togawa et al., 1994), Japan (Mori et al., 1989), South Africa (Williamson et al., 
1991; Copper et al., 1995), Hong Kong (Toh et al., 1992), Slovenia(Polijak eta!., 1998), Portugal 
(Fidalgo et al., 1995), and the United State (Togawa et al., 1994). However the incidence of infection 
differs based on the geographical location of the patient population under study. HPV detection rates 
vary from 0-70%, depending on the regions llllder study (Benarnouz:ing et al., 1995). The highest of 
HPV isolation has been reported from high-risk regions of china and South Africa (Maniatis et al., 
1989). 
In present study, HPV-16, which has a potential for oncogensis, was the most prevalent 
among the esophageal cancer cases examined together with HPV types 52 and 66. The data indicate 
that the infection with oncogenic DNA viruses such as HPV, may be a factor in development of cancer 
by itself or in synergism with other factors including environmental carcinogens, foods, health habits, 
and hereditary factors. But we also folllld various type of HPV in 58% non-cancerous tissues of 
esophagus.These results imply two different interpretations: 1) Due to non-significant difference 
between the rate of HPV positive in cancerous and non-cancerous tissues, may be HPV has no 
important role in esophageal cancers, which is less probable. 2) Because of a highly incidence of 
esophageal cancer in Turkrnen-Sahra region, the HPV is a possible etiologic agent in esophageal 
carcinogenesis, most probably acting synergistically with physical, chemical and/or nutritional factors 
that have previously been folllld to be related to this malignancy in Turkrnen-Sahra. 
We don't have any evidence to determine whether infection with HPV preceded or followed the 
development of squamous cell carcinoma. Further studies are required to pinpoint the cases of 
esophageal cancer in this area. 
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